PRESS RELEASE published on 03/27/2023 at 17:45, 1 year 7 months ago EQS-Adhoc: Airbus reports share buybacks for week starting 20 March 2023
PRESS RELEASE published on 03/20/2023 at 17:45, 1 year 8 months ago EQS-Adhoc: Airbus reports share buyback transactions 13-17 March 2023
PRESS RELEASE published on 03/13/2023 at 17:45, 1 year 8 months ago EQS-Adhoc: Airbus reports share buyback transactions 6-10 March 2023
PRESS RELEASE published on 03/06/2023 at 17:45, 1 year 8 months ago EQS-Adhoc: Airbus reports share buyback transactions 27 Feb to 3 March 2023
PRESS RELEASE published on 02/16/2023 at 06:30, 1 year 9 months ago EQS-Adhoc: Airbus reports Full-Year (FY) 2022 results
Published on 11/22/2024 at 23:55, 9 hours 25 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 50 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 15 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 50 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 5 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 26 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 24 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 20 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
